US Patent Issued to Northwestern University on Feb. 18 for "Compositions comprising peptides comprising variant kinesin light chain 1 and cell-penetrating peptides" (Illinois Inventor)

ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,226,444, issued on Feb. 18, was assigned to Northwestern University (Evasnton, Ill.).

"Compositions comprising peptides comprising variant kinesin light chain 1 and cell-penetrating peptides" was invented by William A. Muller (Evanston, Ill.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compositions and methods for inhibiting tumor cell transendothelial migration by inhibition of kinesin light chain 1, variant 1 (KLC1C) expression and/or activity, and treatment or prevention of cancer and/or metastasis therewith."

The patent was filed on March 11, 2022, under Application No. 17/692,471.

*For further information, including images, ...